DBV TECHNOLOGIES SA-SPON ADR (DBVT) Fundamental Analysis & Valuation

NASDAQ:DBVT • US23306J2006

Current stock price

19.64 USD
-0.33 (-1.65%)
At close:
19.64 USD
0 (0%)
After Hours:

This DBVT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DBVT Profitability Analysis

1.1 Basic Checks

  • DBVT had negative earnings in the past year.
  • DBVT had a negative operating cash flow in the past year.
  • DBVT had negative earnings in each of the past 5 years.
  • DBVT had a negative operating cash flow in each of the past 5 years.
DBVT Yearly Net Income VS EBIT VS OCF VS FCFDBVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • DBVT has a Return On Assets of -63.05%. This is in the lower half of the industry: DBVT underperforms 62.21% of its industry peers.
  • DBVT has a Return On Equity (-87.19%) which is in line with its industry peers.
Industry RankSector Rank
ROA -63.05%
ROE -87.19%
ROIC N/A
ROA(3y)-92.3%
ROA(5y)-76.57%
ROE(3y)-185.25%
ROE(5y)-140.82%
ROIC(3y)N/A
ROIC(5y)N/A
DBVT Yearly ROA, ROE, ROICDBVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • DBVT has a Gross Margin of 86.43%. This is amongst the best in the industry. DBVT outperforms 87.98% of its industry peers.
  • In the last couple of years the Gross Margin of DBVT has declined.
  • The Profit Margin and Operating Margin are not available for DBVT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-2.4%
DBVT Yearly Profit, Operating, Gross MarginsDBVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DBVT Health Analysis

2.1 Basic Checks

  • DBVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DBVT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DBVT has more shares outstanding
  • DBVT has a better debt/assets ratio than last year.
DBVT Yearly Shares OutstandingDBVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
DBVT Yearly Total Debt VS Total AssetsDBVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 8.43 indicates that DBVT is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of DBVT (8.43) is better than 78.88% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that DBVT is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.03, DBVT perfoms like the industry average, outperforming 43.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 8.43
ROIC/WACCN/A
WACC8.02%
DBVT Yearly LT Debt VS Equity VS FCFDBVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • DBVT has a Current Ratio of 3.67. This indicates that DBVT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of DBVT (3.67) is comparable to the rest of the industry.
  • A Quick Ratio of 3.67 indicates that DBVT has no problem at all paying its short term obligations.
  • With a Quick ratio value of 3.67, DBVT perfoms like the industry average, outperforming 47.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.67
DBVT Yearly Current Assets VS Current LiabilitesDBVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DBVT Growth Analysis

3.1 Past

  • DBVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.66%, which is quite impressive.
  • Looking at the last year, DBVT shows a very strong growth in Revenue. The Revenue has grown by 35.77%.
  • Measured over the past years, DBVT shows a small growth in Revenue. The Revenue has been growing by 0.50% on average per year.
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
Revenue 1Y (TTM)35.77%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%

3.2 Future

  • DBVT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.84% yearly.
  • Based on estimates for the next years, DBVT will show a very strong growth in Revenue. The Revenue will grow by 155.17% on average per year.
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y10.62%
Revenue Next 5Y155.17%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DBVT Yearly Revenue VS EstimatesDBVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
DBVT Yearly EPS VS EstimatesDBVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. DBVT Valuation Analysis

4.1 Price/Earnings Ratio

  • DBVT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DBVT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DBVT Price Earnings VS Forward Price EarningsDBVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DBVT Per share dataDBVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.4%
EPS Next 3Y10.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DBVT Dividend Analysis

5.1 Amount

  • No dividends for DBVT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DBVT Fundamentals: All Metrics, Ratios and Statistics

DBV TECHNOLOGIES SA-SPON ADR

NASDAQ:DBVT (4/22/2026, 4:30:01 PM)

After market: 19.64 0 (0%)

19.64

-0.33 (-1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-26
Earnings (Next)07-27
Inst Owners44.96%
Inst Owner Change0.01%
Ins Owners0.08%
Ins Owner Change29.3%
Market Cap1.16B
Revenue(TTM)5.64M
Net Income(TTM)-147.16M
Analysts80
Price Target31.33 (59.52%)
Short Float %3%
Short Ratio6.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-51.04%
Min EPS beat(2)-107.02%
Max EPS beat(2)4.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)161.83%
Min Revenue beat(2)4.35%
Max Revenue beat(2)319.32%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)29.32%
PT rev (3m)44.96%
EPS NQ rev (1m)-43.78%
EPS NQ rev (3m)5.95%
EPS NY rev (1m)-25.81%
EPS NY rev (3m)-168.15%
Revenue NQ rev (1m)0.55%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)-24.64%
Revenue NY rev (3m)-99.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 206.24
P/FCF N/A
P/OCF N/A
P/B 6.89
P/tB 6.89
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)-2.6
Fwd EYN/A
FCF(TTM)-2.04
FCFYN/A
OCF(TTM)-2.04
OCFYN/A
SpS0.1
BVpS2.85
TBVpS2.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -63.05%
ROE -87.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.43%
FCFM N/A
ROA(3y)-92.3%
ROA(5y)-76.57%
ROE(3y)-185.25%
ROE(5y)-140.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-2.4%
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.15%
Cap/Sales 9.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.67
Quick Ratio 3.67
Altman-Z 8.43
F-Score5
WACC8.02%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)23.42%
Cap/Sales(5y)20.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue 1Y (TTM)35.77%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y10.62%
Revenue Next 5Y155.17%
EBIT growth 1Y-26.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.74%
OCF growth 3YN/A
OCF growth 5YN/A

DBV TECHNOLOGIES SA-SPON ADR / DBVT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DBV TECHNOLOGIES SA-SPON ADR?

ChartMill assigns a fundamental rating of 3 / 10 to DBVT.


What is the valuation status for DBVT stock?

ChartMill assigns a valuation rating of 0 / 10 to DBV TECHNOLOGIES SA-SPON ADR (DBVT). This can be considered as Overvalued.


What is the profitability of DBVT stock?

DBV TECHNOLOGIES SA-SPON ADR (DBVT) has a profitability rating of 1 / 10.


Can you provide the financial health for DBVT stock?

The financial health rating of DBV TECHNOLOGIES SA-SPON ADR (DBVT) is 5 / 10.


Can you provide the expected EPS growth for DBVT stock?

The Earnings per Share (EPS) of DBV TECHNOLOGIES SA-SPON ADR (DBVT) is expected to decline by -36.93% in the next year.